Kerala: Amoebic Encephalitis Antidote Miltefoscin To Reach Thiruvananthapuram From Germany
Date
7/29/2024 3:40:23 AM
(MENAFN- AsiaNet News) Thiruvananthapuram: The antidote for the rare brain-eating amoeba infection or amoebic encephalitis will arrive from Germany today in the state's capital. The life-saving drug Miltefoscin was earlier administered to a young boy aged 14, reported to be infected with the condition in Kozhikode's Baby Memorial Hospital.
Kerala: Teenage boy dies of amoebic meningitis in Kozhikode; third death in two months
Dr. Abdul Rauf said in a press conference that early detection of the disease helped save the child. Early detection of the disease is beneficial. He said the medicine was delivered by the health department from Germany and was administered to the child.
The boy was brought back to life from a disease with a 97 percent mortality rate.
Steps have also been taken to deliver more batches of medicines in the coming days.
Reports indicate that in the past one-and-a-half-month, amoebic encephalitis has claimed the lives of three children. The deceased are 12-year-old Mridul from Farook, 13-year-old Dakshina from Kannur and 5-year-old Fadwa from Malappuram.
The 'brain-eating amoeba' thrives in environments such as lakes, hot springs, and stagnant water, entering the body through the nose. Reports have also identified it in unmanaged swimming pools, surf parks, and other recreational areas.
The organism infects individuals through the nasal passage and migrates to the brain, causing Primary Amoebic Meningoencephalitis (PAM). Initial symptoms typically emerge within 5 days, but can appear anywhere between 1-12 days after infection. Mild symptoms include headache, fever, nausea, and vomiting, while severe cases can progress to hallucinations, seizures, confusion, and even coma. If left untreated, PAM can be fatal within a month.
Kerala: 5-year-old girl undergoing treatment for rare brain infection dies at Kozhikode MCH
MENAFN29072024007385015968ID1108492659
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.